The control of the delivery of transferrin iron and other forms of iron to cells by chelators, and also through the modulation of transferrin receptors, can affect key enzymes and other organic biomolecules in cancer cells and may have an application in the design of specific anticancer therapeutic strategies [8,212,213,214,215]. Here, TFRC is linked to cancer.